WATCH and LISTEN on every major podcast platform,
and make sure to follow DeviceTalks to never miss an episode.
Over 60 years ago, engineer Miles Lowell Edwards and surgeon Dr. Albert Starr launched a company and an industry by developing the first commercially available artificial heart valve.
Today, Edwards Lifesciences is focusing its attention on developing life-saving and groundbreaking devices that can help patients with heart valve disease.
In this podcast series, we'll talk with the Edwards Lifesciences leaders who are adding to this great MedTech story.
SEE WHAT'S NEW
1
In the inaugural episode, we sit down with Daveen Chopra, Corporate VP and GM of TMTT. In the episode, Chopra discusses the unique challenges of advancing therapies for the mitral and tricuspid valves, which have historically been more difficult...
2
In this episode, Wayne Markowitz, GM and Senior VP, Surgical Structural Heart discusses the evolving landscape of the structural heart space, emphasizing the renewed focus at Edwards under new leadership. Markowitz highlights the importance...
3
In this episode, Larry Wood, CVP and Group President, TAVR and Surgical Structural Heart discusses the transformative journey of TAVR and the SAPIEN valve. Wood reflects on the innovation that enables minimally invasive heart valve replacement...
5
We sit down with Edwards' Joseph Nuzzolese, Corporate VP, Global Supply Chain & Quality
In this episode of Structural Heart Talks, host Tom Salemi sits down with Joseph Nuzzolese, Corporate VP, Global Supply Chain & Quality. Episode details coming soon. Subscribe to the DeviceTalks Podcast Network to get access when it airs this January.
4
We sit down with Edwards' Todd Brinton, MD, Chief Scientific Officer & CVP, Advanced Technology
In this episode of Structural Heart Talks, host Tom Salemi sits down with Todd Brinton to discuss Todd’s winding path to Edwards and leading the AT team to innovate around unmet patient needs. Subscribe to get access when it airs this December.
Watch or listen to Structural Heart Talks and more MedTech-focused podcasts from the DeviceTalks Podcast Network on YouTube and all major podcast platforms. Subscribe to never miss an episode!
LISTEN ON YOUR FAVORITE PODCAST PLATFORM
MEET OUR PARTNERS
Confluent specializes in the expert design, development, and large-scale manufacturing of interventional catheter-based devices and implants. Our key capabilities include Nitinol components and tubing, balloon and complex catheters, high-precision polymer tubing, and implantable textiles.
Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, Integer is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions.
We are a global leader in advanced engineering, prototyping, product development, and micro manufacturing. We collaborate with our customers, enabling them to develop breakthrough medical devices and products and expand the possibilities of medical technology - with the goal to improve patient care worldwide. We support projects at all levels, from initial concept to design, prototyping, and high-volume manufacturing.
AMPLIFY YOUR MESSAGE
Share your message and increase your brand recognition in the MedTech industry, today.
Colleen Sepich, Event Sales Director
csepich@wtwhmedia.com
857-260-1360
Tom Salemi
tsalemi@wtwhmedia.com
978-518-0310
For registration or logistic questions, contact
